Quent Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.74M Buy
10,802
+289
+3% +$67.4K 0.17% 82
2026
Q1
$2.57M Buy
10,513
+48
+0.5% +$11.2K 0.18% 70
2025
Q4
$2.17M Buy
10,465
+2,034
+24% +$402K 0.16% 87
2025
Q3
$1.56M Buy
8,431
+757
+10% +$130K 0.13% 82
2025
Q2
$1.17M Buy
7,674
+507
+7% +$77.9K 0.11% 88
2025
Q1
$1.19M Buy
7,167
+345
+5% +$54K 0.12% 80
2024
Q4
$987K Sell
6,822
-1,077
-14% -$167K 0.1% 91
2024
Q3
$1.28M Buy
7,899
+70
+0.9% +$11.2K 0.13% 95
2024
Q2
$1.14M Sell
7,829
-2,004
-20% -$298K 0.13% 95
2024
Q1
$1.56M Sell
9,833
-120
-1% -$19.1K 0.18% 74
2023
Q4
$1.56M Sell
9,953
-569
-5% -$87.2K 0.21% 68
2023
Q3
$1.64M Sell
10,522
-375
-3% -$61.9K 0.26% 58
2023
Q2
$1.8M Sell
10,897
-253
-2% -$40.8K 0.28% 52
2023
Q1
$1.73M Buy
11,150
+582
+6% +$94K 0.29% 51
2022
Q4
$1.87M Buy
10,568
+897
+9% +$155K 0.34% 47
2022
Q3
$1.58M Buy
9,671
+1,032
+12% +$175K 0.33% 47
2022
Q2
$1.53M Buy
8,639
+255
+3% +$45.4K 0.33% 45
2022
Q1
$1.49M Buy
8,384
+3,685
+78% +$627K 0.28% 56
2021
Q4
$804K Buy
+4,699
New +$769K 0.17% 103

Other funds holding JNJ

Quent Capital's JNJ Position: Q2 2026 in Review

Quent Capital increased its Johnson & Johnson (JNJ) stake by 2.7% in Q2 2026, buying an estimated $67.4K and bringing the position to 10,802 shares worth $2.74M. The position accounts for 0.17% of the portfolio, ranked #82.

Quent Capital first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Quent Capital held 10,802 shares of Johnson & Johnson worth $2.74M as of Q2 2026.
  • Quent Capital bought 289 Johnson & Johnson shares in Q2 2026, an estimated $67.4K.
  • Johnson & Johnson made up 0.17% of Quent Capital's portfolio in Q2 2026, its #82 holding.
  • Quent Capital first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.